The most widely prescribed growth hormone peptide combination. Ipamorelin and CJC-1295 work on two separate receptor pathways simultaneously — producing a more powerful, sustained GH pulse than either peptide alone.
GH release is regulated by two hormones: GHRH (which stimulates release) and ghrelin/GHRP signals (which potentiate it). Ipamorelin and CJC-1295 target each pathway independently — when combined, they produce a synergistic GH pulse significantly larger than either can generate alone.
A highly selective growth hormone releasing peptide (GHRP) that stimulates the pituitary directly. Unlike earlier GHRPs, ipamorelin does not meaningfully elevate cortisol or prolactin — making it exceptionally clean.
A modified GHRH analog with an extended half-life. CJC-1295 keeps GH levels elevated for a longer period by acting on the hypothalamus to continuously stimulate the GH axis.
GH is released during sleep. Optimizing GH production restores slow-wave sleep depth and morning recovery quality.
Higher GH and IGF-1 levels support protein synthesis and lean mass retention — especially important for active adults over 40.
GH directly activates lipolysis. Patients consistently report improved body composition — more muscle, less fat — at 8–12 weeks.
Patients typically report meaningful improvements in daily energy, motivation, and workout endurance within the first 4–8 weeks.
Faster muscle repair between training sessions. Less soreness, better next-day performance, reduced injury risk.
GH receptors exist throughout the brain. Many patients notice improved mental sharpness and mood stability as GH is restored.
IGF-1 upregulates collagen synthesis. Improved skin quality, reduced wrinkle depth, and better skin elasticity are common at 3–6 months.
IGF-1 is critical for bone metabolism. Long-term GH optimization may help preserve bone density and reduce fracture risk.
Discuss your goals, current symptoms, and any relevant history. Dr. Paul confirms whether the ipamorelin/CJC-1295 stack is appropriate for you.
IGF-1 is the primary marker of GH status. We include it in our full blood panel to establish your baseline and guide dosing.
The combination is typically dosed as a single subcutaneous injection once daily at bedtime, or 2–3x daily for more aggressive protocols. Compounded by a licensed pharmacy, delivered to your door.
IGF-1 is rechecked at 8–12 weeks. Protocols are adjusted based on response. Most patients continue for 3–6 months, with periodic breaks.
Ipamorelin/CJC-1295 produces a larger and more sustained GH pulse by activating two different receptor pathways simultaneously. Sermorelin is excellent, but the combination stack is typically more potent — making it the preferred option for patients with more significant GH decline.
Yes. Both ipamorelin and CJC-1295 are non-controlled peptides. Juvenis Medical prescribes them to patients in all 50 states via telehealth — no Florida residency required.
Ipamorelin is one of the cleanest GH-releasing peptides — it does not meaningfully raise cortisol, prolactin, or hunger (unlike older GHRPs). The most common side effects are mild water retention and temporary tingling at the injection site, both of which typically resolve with dose adjustments.
Better sleep often comes within 1–2 weeks. Noticeable changes in energy and recovery at 4–6 weeks. Body composition improvements — more muscle, less fat — are clearly apparent at 8–16 weeks of consistent use.
Absolutely. GH declines in both men and women with age, and both benefit from restoration. Women often notice particularly significant improvements in body composition, skin quality, and energy.
Available via telehealth to all 50 states. Free 15-minute consultation to find out if you're a candidate.
Book Free Consultation →